Back
Adaptive Biotechnologies Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
38
ADPT
Adaptive Biotechnologies
Last Price:
4.67
Seasonality Move:
-1.77%
Sell
30
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-0.57%
Sell
38
Adaptive Biotechnologies (ADPT)
is a Sell
Is Adaptive Biotechnologies a Buy, Sell or Hold?
- The current Adaptive Biotechnologies [ADPT] share price is $4.68. The Score for ADPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ADPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.70. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADPT Stock Price Chart
What is Adaptive Biotechnologies's stock price today?
-
The Adaptive Biotechnologies share price today is $4.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.70
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
ADPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 41.81 | Sell |
Chaikin Money Flow: | -1263705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.6 - 5.68) | Sell |
Bollinger Bands (100): | (4.03 - 5.19) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 51.73 | Buy |
Chaikin Money Flow: | -26155 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.74) | Buy |
Bollinger Bands (100): | (0.28 - 1.54) | Sell |
ADPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.63 | Sell |
20-day SMA: | 5.23 | Sell |
50-day SMA: | 4.95 | Sell |
200-day SMA: | 3.98 | Buy |
8-day EMA: | 5.38 | Sell |
20-day EMA: | 5.31 | Sell |
50-day EMA: | 5.01 | Sell |
200-day EMA: | 4.56 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.72 | Sell |
20-day SMA: | 0.68 | Buy |
50-day SMA: | 0.64 | Buy |
200-day SMA: | 2.41 | Sell |
8-day EMA: | 0.71 | Sell |
20-day EMA: | 0.7 | Buy |
50-day EMA: | 0.74 | Sell |
200-day EMA: | 5.77 | Sell |
Adaptive Biotechnologies Earnings Growth & ADPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.26 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Adaptive Biotechnologies Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |